A药品名称: B药品名称: B与A对换
 药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
A药品
B药品
详细
Potassium cation
7-Nitroindazole
The risk or severity of adverse effects can be increased when Cannabidiol is combined with 7-Nitroindazole.
Potassium cation
Rolipram
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Rolipram.
Potassium cation
Pargyline
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Pargyline.
Potassium cation
Zuclopenthixol
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Zuclopenthixol.
Potassium cation
Thioproperazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Thioproperazine.
Potassium cation
Molindone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Molindone.
Potassium cation
Alverine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Alverine.
Potassium cation
Aceprometazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Aceprometazine.
Potassium cation
Acepromazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Acepromazine.
Potassium cation
Periciazine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Periciazine.
Potassium cation
Nitrazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Nitrazepam.
Potassium cation
Cinolazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cinolazepam.
Potassium cation
Quazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Quazepam.
Potassium cation
Prazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Prazepam.
Potassium cation
Fludiazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Fludiazepam.
Potassium cation
Dihydromorphine
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Dihydromorphine.
Potassium cation
Chloral hydrate
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Chloral hydrate.
Potassium cation
Cathinone
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Cathinone.
Potassium cation
Clotiazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Clotiazepam.
Potassium cation
Bromazepam
The risk or severity of adverse effects can be increased when Cannabidiol is combined with Bromazepam.
免责声明:以上所展示的信息由企业自行提供,内容的真实性、准确性和合法性由发布企业负责,医药网对此不承担任何责任。
相关链接:医药研究数据| 医药资料| SDA药品评审中心| 中医网| 中药处方系统| 爱视立眼贴
专业提供药品信息、药品招商、药品代理、保健品招商、医药原料采购供应的中国药品信息网站平台
版权所有 © 2003-2028 盗冒必究  客服热线:0575-83552251 / 13754370441  QQ客服:药品信息客服
浙ICP备16010490号-2 增值电信业务经营许可证:浙B2-20220931 互联网药品信息服务资格证书编号:(浙)-经营性2023-0215 浙公网安备:330683240604819103159
 医药代理商群1:药药网药品采购交流医药代理商群2:药药网药品采购交流2医药代理商群3:药药网药品采购交流3